Sanofi, top fourth ranking company in the pharmaceutical sector has signed new MOU, pharma deals with Sinopharm, in Shanghai to conduct joint research into rare diseases.
Although details of these pharma deals haven’t been released, the collaboration will apparently survey the incidence of rare diseases in China, then seek to understand causes and find treatments.
For further deal information visit Current Agreements (subscription required)
Read: more on partnering deals in pharma, biotech, life science partnering deal news, insights and glossary
Related reports: Bigpharma Partnering Yearbook 2013
View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk
View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value
View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making
View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity